| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 02/05/2004 | US20040022831 For therapy of mycosis of the nail |
| 02/05/2004 | US20040020404 Printing an image on a substrate comprising applying thereto a formulation comprising a liquid medium and a compound containing azo groups and metallized 1,8-dihydroxynaphthyl group |
| 02/05/2004 | DE10234288A1 Metallkomplexe als lichtabsorbierende Verbindungen in der Informationsschicht von optischen Datenträgern Metal complexes as light-absorbing compounds in the information layer of optical media |
| 02/05/2004 | DE10231368A1 Verfahren zur Herstellung von Imidazoliumsalzen Process for the preparation of imidazolium salts |
| 02/05/2004 | CA2533587A1 Compounds active in sphingosine 1-phosphate signaling |
| 02/05/2004 | CA2495167A1 Structural carotenoid analogs for the inhibition and amelioration of disease |
| 02/05/2004 | CA2493924A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect |
| 02/05/2004 | CA2493751A1 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 02/05/2004 | CA2492210A1 Aryl substituted hydantoin compounds and their use as sodium channel blockers |
| 02/04/2004 | EP1386916A1 Process for the monomethylation of nitrogen containing heterocycles |
| 02/04/2004 | EP1386915A1 Azole compounds, process for preparation of the same and use thereof |
| 02/04/2004 | EP1386912A1 Cyclic amidine derivative |
| 02/04/2004 | EP1385828A1 Compounds of the family of 3-alkyl-(4,5 dipheny-imidazol-1-yl) and their use as soothing agents |
| 02/04/2004 | EP1385827A1 Novel compounds of the family of 3-alkyl-(4,5 diphenyl-imidazol-1-yl) and their use as soothing agents |
| 02/04/2004 | EP1385820A1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
| 02/04/2004 | EP1385517A1 Novel oral general anesthetics and metabolitically resistant anticonvulsants |
| 02/04/2004 | EP0983264B1 Method of manufacturing sertindole |
| 02/04/2004 | EP0730404B1 Amphiphilic imidazolinium derivatives |
| 02/04/2004 | CN1473150A Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 02/04/2004 | CN1137083C New benzocyclobutane compounds, process for their preparation and pharmaceutical compositions containing them |
| 02/03/2004 | US6686397 Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity |
| 02/03/2004 | US6686395 2′-substituted 1,1′-biphenyl-2-carboxamides, process for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
| 02/03/2004 | US6686367 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 02/03/2004 | US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 02/03/2004 | US6686350 Cell adhesion inhibitors |
| 02/03/2004 | US6686345 DNA-cleaving antitumor agents |
| 02/03/2004 | CA2067151C Aica riboside analogs |
| 02/01/2004 | CA2434481A1 Process for the methylation of nitrogenated heterocyclics |
| 01/29/2004 | WO2004009558A2 Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations |
| 01/29/2004 | WO2004009034A2 Thiomolybdate analogues and uses thereof |
| 01/29/2004 | WO2004009017A2 Modulators of the glucocorticoid receptor and method |
| 01/29/2004 | WO2003066035A3 Compounds for inhibiting insulin secretion and methods related thereto |
| 01/29/2004 | WO2003035613A3 Nitrogen heterocycle inhibitors of aspartyl protease |
| 01/29/2004 | US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2004 | US20040019211 Crystal structured fungicides selected from itraconazole, posaconazole or saperconazole used for prevention or prophylaxis of fungi, yeasts and dermatophyte infections |
| 01/29/2004 | US20040019106 Cyano and carboxy derivatives of substituted styrenes; inhibitors of tumor necrosis factor alpha, nuclear factor kappa B, and phosphodiesterase |
| 01/29/2004 | US20040019087 Thiomolybdate analogues and uses thereof |
| 01/29/2004 | US20040019043 Thiomolybdate analogues and uses thereof |
| 01/29/2004 | CA2493458A1 Ureido substituted benzoic acid compounds, their use for nonsense suppression and the treatment of diseases caused by such mutations |
| 01/29/2004 | CA2493127A1 Thiomolybdate analogues and uses thereof |
| 01/28/2004 | EP1384715A1 Novel imidazolidinedione derivatives and use thereof as drugs |
| 01/28/2004 | EP1383760A1 Biarylcarboxamide compounds as apolipoprotein b inhibitors |
| 01/28/2004 | EP1383731A1 Biaryl compounds as serine protease inhibitors |
| 01/28/2004 | CN1471524A Novel farnesyl protein transferase inhibitors as antitumor |
| 01/28/2004 | CN1471514A Novel M-amino-phenylimino-imidazolidone derivatives for treating urinary incontinence |
| 01/28/2004 | CN1471506A Method for preparing carbonyl alpha-substituted nitrogen compounds |
| 01/28/2004 | CN1471394A Tripeptidyl peptidase inhibitors |
| 01/28/2004 | CN1136204C Process for preparing 2-imidazoline-5-one fungicide |
| 01/28/2004 | CN1136193C Imide derivatives ar Salts thereof |
| 01/27/2004 | US6683215 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 01/27/2004 | US6683191 Preparing a azole compound on a solid support resin, cleaving the compound from the solid support resin by nucleophilic substitution to further substituting by alkylation reaction |
| 01/27/2004 | US6683190 Contacting racemic hydantoin with enantiomeric splitting agent; decyclization |
| 01/27/2004 | US6683189 Method for the synthesis of pyrrole and imidazole carboxamides on a solid support |
| 01/27/2004 | US6683180 Method for the production of caprolactam |
| 01/27/2004 | US6683097 Imidazole derivatives |
| 01/22/2004 | WO2004007465A1 Method for producing imidazolium salts |
| 01/22/2004 | WO2004007464A1 Imidazole derivative |
| 01/22/2004 | WO2004007439A1 Biaryl derivatives |
| 01/22/2004 | WO2002074268A3 Dyeing compositions for the dyeing of keratin fibres, comprising heterocyclic hydrazone compounds |
| 01/22/2004 | US20040014968 Such as 2-(3-chloro-phenyl)-3-cyclopentyl-N-thiazol-2-yl-propionamide which increases insulin secretion in treatment of type II diabetes |
| 01/22/2004 | US20040014758 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 01/21/2004 | EP1382626A1 Modified isocyanates |
| 01/21/2004 | EP1382333A2 Use of beta 3 adrenergic receptor agonists in the treatment of dysuria |
| 01/21/2004 | EP1381595A1 Bis(trifluoromethyl)hydantoins as intermediates for pharmaceutically active ingredients |
| 01/21/2004 | EP1305028A4 Antimicrobial biaryl compounds |
| 01/21/2004 | EP1254092B1 Resolution of dl-racemic mixtures |
| 01/21/2004 | EP1140794B1 Novel method for preparing chiral amino acids |
| 01/21/2004 | EP1019048B1 Use of an angiotensin ii receptor antagonist for the preparation of drugs to increase the survival rate of renal transplant patients |
| 01/21/2004 | EP0981366B1 Selective mmp inhibitors having reduced side-effects |
| 01/21/2004 | CN1469876A Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 01/21/2004 | CN1135236C 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 01/20/2004 | US6680333 Imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 01/20/2004 | CA2274621C New nitrone derivatives, their preparation method and pharmaceutical compositions comprising them |
| 01/15/2004 | WO2004005407A2 Tetra-azapentamethine and use thereof for dyeing keratinous fibers |
| 01/15/2004 | WO2004005264A2 Imidazole compounds for the treatment of hepatitis c virus infections |
| 01/15/2004 | WO2004004655A2 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 01/15/2004 | WO2004004462A1 Biocidal composition containing halogenated hydantoin and paraffin wax |
| 01/15/2004 | WO2003082216A3 Neuroprotectant methods, compositions, and screening methods thereof |
| 01/15/2004 | WO2003053895A3 Copper deposition using copper formate complexes |
| 01/15/2004 | WO2003041658A3 Process for the preparation of 3,7-disubstituted-2,3,4,5- tetrahydro-1h-1,4-benzodiazepine compounds |
| 01/15/2004 | WO2002055025A3 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 01/15/2004 | US20040010056 Mixture of polymer and dye |
| 01/15/2004 | US20040010037 Cyanophenyl derivative |
| 01/15/2004 | US20040010024 Particulate blends and compacted products formed therefrom, and the preparation thereof |
| 01/15/2004 | US20040010023 Biphenyl derivatives and the use thereof as integrin inhibitors |
| 01/15/2004 | US20040009998 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 01/15/2004 | US20040009979 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 01/15/2004 | US20040009976 Hypoglycemic imidazoline compounds |
| 01/15/2004 | US20040009969 Diazacycloalkanes containing a 2,5-dioxo-1H-pyrrolyl- or 4-oxo-2-thioxoimidazolidinyl- groups; treating prostate cancer, benign prostate hyperplasia, androgenetic alopecia, hirsutism and androgen-dependent acne. |
| 01/15/2004 | US20040009923 Alpha-substituted methyl ketones derived from aspartic acid and the closed hemi-ketal forms thereof |
| 01/15/2004 | US20040009122 A formulation V-L-R where v is a vector moiety having affinity for an angiogenesis-related endothelial cell receptor, L is a linker or a bond and R is a detectable moiety (v is nonpeptidic or peptide and R is a macromolecule) |
| 01/14/2004 | EP1379514A2 5-membered heterocycles, preparation and application thereof as medicaments |
| 01/14/2004 | EP1379508A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 01/14/2004 | EP1379498A1 Sulphones which modulate the action of gamma secretase |
| 01/14/2004 | EP1379496A1 Sulphones which modulate the action of gamma secretase |
| 01/14/2004 | EP1379493A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 01/14/2004 | EP1379485A1 Selective ring-opening cross-metathesis of cycloolefins |
| 01/14/2004 | EP1379241A1 Compounds and methods |
| 01/14/2004 | EP1379239A2 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 01/14/2004 | EP1227811B1 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of disease states as a result of ischaemic conditions |